Application 216278
- Type
- ANDA
- Sponsor
- AMNEAL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TIOPRONIN | TIOPRONIN | TABLET, DELAYED RELEASE;ORAL | 300MG | No | No |
| 002 | TIOPRONIN | TIOPRONIN | TABLET, DELAYED RELEASE;ORAL | 100MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A216278-001 | TIOPRONIN | TIOPRONIN | 300MG | TABLET, DELAYED RELEASE / ORAL | 2023-08-15 | ||
| A216278-002 | TIOPRONIN | TIOPRONIN | 100MG | TABLET, DELAYED RELEASE / ORAL | 2025-08-29 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A216278-001 | TIOPRONIN | 300MG | TABLET, DELAYED RELEASE / ORAL | 2023-08-15 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | A216278-002 | TIOPRONIN | 100MG | TABLET, DELAYED RELEASE / ORAL | 2025-08-29 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| tiopronin | TIOPRONIN | Amneal Pharmaceuticals NY LLC | ce5b1f97-5b3c-40b6-b1c4-1d36025be1b8 | 2023-05-01 | Warnings, Adverse reactions | 216278 ANDA216278 |